Theophylline increases on time in advanced parkinsonian patients

Neurology

Volumn 52, Issue 9, 1999, Pages 1916-

  Kostic, V S ^a   Suetel, M ^b   Sternic, N ^c   Dragaseuic, N ^c   Przedborski, S ^b  

^a Institute of Neurology Clinical Centre of Serbia   (Yugoslavia)

^b Neurological Institute

^c Howard Hughes Medical Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

THEOPHYLLINE;

ADULT; ARTICLE; CLINICAL ARTICLE; DRUG ACTIVITY; DRUG EFFECT; DYSKINESIA; HUMAN; PARKINSONISM; PRIORITY JOURNAL; RECEPTOR BLOCKING; SIDE EFFECT; TREATMENT OUTCOME;

ADULT; HUMANS; MIDDLE AGED; PARKINSON DISEASE; THEOPHYLLINE; TIME FACTORS;

EID: 0032976575     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.52.9.1916     Document Type: Article

References (5)

1. Kostic V, Przedborski S, Plaster E, Sternic N. Early development of levodopa-induced dyskinesias and response fluctuations in young-onset Parkinson's disease. Neurology 1991;41:202-205.
2. 2A adenosine receptor antagonist KW-6002 has antiparkinsonian activity in MPTP-treated cynoraolgus monkeys. Mov Disord 1998;13(suppl 2):254. Abstract.
3. 2 dopamine receptors in rat striatum. Mol Brain Res 1992;14:186-195.
4. Jiang H, Jackson-Lewis V, Muthane U, et al. Adenosine receptor antagonists potentiate dopamine receptor agonist-induced rotational behavior in 6-hydroxydopamine-lesioned rats. Brain Res 1993;613:347-351.
5. 18F-fluorodeoxyglucose and positron emission tomography. Neurology 1995;45:1995-2004.